CMV RNA-pulsed dendritic cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMV RNA-pulsed dendritic cells, covering 2021-01-28 to 2021-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma [Phase 1]